1. Home
  2. DNA vs BTX Comparison

DNA vs BTX Comparison

Compare DNA & BTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

BUY

Current Price

$11.22

Market Cap

835.7M

Sector

Health Care

ML Signal

BUY

Logo BlackRock Technology and Private Equity Term Trust

BTX

BlackRock Technology and Private Equity Term Trust

N/A

Current Price

$9.23

Market Cap

770.3M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
DNA
BTX
Founded
2008
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
835.7M
770.3M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
DNA
BTX
Price
$11.22
$9.23
Analyst Decision
Sell
Analyst Count
3
0
Target Price
★ $7.00
N/A
AVG Volume (30 Days)
★ 3.0M
412.0K
Earning Date
11-05-2026
11-01-2025
Dividend Yield
N/A
★ 6.82%
EPS Growth
★ 46.49
N/A
EPS
N/A
★ N/A
Revenue
★ $170,155,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$13.37
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$5.37
$6.13
52 Week High
$18.22
$9.49

Technical Indicators

Market Signals
Indicator
DNA
BTX
Relative Strength Index (RSI) 56.80 57.66
Support Level $6.86 $8.79
Resistance Level N/A $9.40
Average True Range (ATR) 1.63 0.15
MACD 0.20 0.04
Stochastic Oscillator 35.01 66.67

Price Performance

Historical Comparison
DNA
BTX

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

About BTX BlackRock Technology and Private Equity Term Trust

BlackRock Technology and Private Equity Term Trust is a closed-end management investment company. Its investment objectives are to provide total return and income through long-term capital appreciation.

Share on Social Networks: